all report title image
  • Published In : Apr 2023
  • Code : CMI5650
  • Pages : 171
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Vaccines are considered as one of the most effective methods for the prevention and control of infectious diseases. This is primarily due to their ability to target specific pathogens and stimulate the immune system. Moreover, these products are also inexpensive and can be used to treat multiple diseases simultaneously.

Market Dynamics:

The global intramuscular vaccine adjuvants market is expected to experience substantial growth during the forecast period due to several factors. These include an increased demand for safe and effective vaccines, the ongoing pace of innovation in this field, and financial support from various private and public sector investors. A growing geriatric population coupled with increasing prevalence of chronic diseases are other major drivers fuelling growth of the global vaccine adjuvants market. Moreover, the presence of large numbers of hospitals and other healthcare facilities is also expected to propel market growth during the forecast period. In addition, the emergence of novel therapeutics is further expected to boost market growth.

On the other hand, side-effects and toxicity of adjuvants is expected to hinder the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global intramuscular vaccine adjuvants market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global intramuscular vaccine adjuvants market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novavax, Inc., Adjuvance Technologies, Inc., Invivogen, Vaxine Pty Ltd., SEPPIC, SPI Pharma, Inc., Agenus Inc., Avanti Polar Lipids, Inc., CSL Limited, and OZ Biosciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global intramuscular vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global intramuscular vaccine adjuvants market

Detailed Segmentation:

  • Global Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants:
    • Oil-based Adjuvants
    • Liposome-based Adjuvants
    • Polymer-based Adjuvants
    • Mineral-based Adjuvants
    • Others
  • Global Intramuscular Vaccine Adjuvants Market, By End Users:
    • Pediatrics
    • Adults
    • Geriatrics
  • Global Intramuscular Vaccine Adjuvants Market, By Applications:
    • Infectious diseases
    • Cancer
    • Others
  • Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels:
    • Hospitals
    • Clinics
    • Research Centers
  • Global Intramuscular Vaccine Adjuvants Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Novavax, Inc.
    • Adjuvance Technologies, Inc.
    • Invivogen
    • Vaxine Pty Ltd.
    • SEPPIC
    • SPI Pharma, Inc.
    • Agenus Inc.
    • Avanti Polar Lipids, Inc.
    • CSL Limited
    • OZ Biosciences

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Intramuscular Vaccine Adjuvants, By Type of Adjuvants
      • Market Intramuscular Vaccine Adjuvants, By  End users
      • Market Intramuscular Vaccine Adjuvants, By Applications
      • Market Intramuscular Vaccine Adjuvants, By Distribution Channels
      • Market Intramuscular Vaccine Adjuvants, By Region
    • Coherent Opportunity Map (COM)
  3. Global Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Growing geriatric population coupled with increasing prevalence of chronic diseases
        • Increased government vaccination recommendations
      • Restraints
        • Side-effects and toxicity of adjuvants
      • Opportunities
        • Increased research and development activities in this field
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Intramuscular Vaccine Adjuvants Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5.  Global Intramuscular Vaccine Adjuvants Market , By Type of Adjuvants, 2023-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2023 – 2030
      • Segment Trends
    • Oil-based Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
    • Liposome-based Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
    • Liposome-based Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
    • Mineral-based Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  6. Global Intramuscular Vaccine Adjuvants Market , By End Users, 2023-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2023 – 2030
      • Segment Trends
    • Pediatrics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
    • Adults
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
    • Geriatrics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
  7. Global Intramuscular Vaccine Adjuvants Market , By Applications, 2023-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2023 – 2030
      • Segment Trends
    • Infectious diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
  8. Global Intramuscular Vaccine Adjuvants Market , By Distribution Channels, 2023-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2023 – 2030
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
    • Research Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
  9. Global Intramuscular Vaccine Adjuvants Market , By Region, 2023-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Country 2023 –2030
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2023-2030,(US$ Mn)
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2023-2030,(US$ Mn)
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2023-2030,(US$ Mn)
    • Middle East & Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2023-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2023-2030,(US$ Mn)
  10. Competitive Landscape
    • Novavax, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Adjuvance Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Invivogen
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Vaxine Pty Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • SEPPIC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • SPI Pharma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Agenus Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Avanti Polar Lipids, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • CSL Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • OZ Biosciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
      • Analyst Views
  11. Section
    • Research Methodology
    • About us

*Browse 24 market data tables and 28 figures on "Intramuscular Vaccine Adjuvants Market” - Global forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo